2,2'-dipyridyl has been researched along with Stroke in 4 studies
2,2'-Dipyridyl: A reagent used for the determination of iron.
2,2'-bipyridine : A bipyridine in which the two pyridine moieties are linked by a bond between positions C-2 and C-2'.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the efficacy of the liposoluble iron chelator 2,2'-dipyridyl (DP) in reducing histological damage in rats submitted to cerebral ischemia and the mechanisms involved in the potential cytoprotection." | 7.72 | Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2'-dipyridyl in the rat photothrombotic ischemic stroke model. ( Beley, A; Bertrand, N; Demougeot, C; Marie, C; Mossiat, C; Prigent-Tessier, A; Van Hoecke, M, 2004) |
| "We examined the efficacy of the liposoluble iron chelator 2,2'-dipyridyl (DP) in reducing histological damage in rats submitted to cerebral ischemia and the mechanisms involved in the potential cytoprotection." | 3.72 | Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2'-dipyridyl in the rat photothrombotic ischemic stroke model. ( Beley, A; Bertrand, N; Demougeot, C; Marie, C; Mossiat, C; Prigent-Tessier, A; Van Hoecke, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caliaperumal, J | 1 |
| Wowk, S | 1 |
| Jones, S | 1 |
| Ma, Y | 1 |
| Colbourne, F | 1 |
| Demougeot, C | 1 |
| Van Hoecke, M | 1 |
| Bertrand, N | 3 |
| Prigent-Tessier, A | 3 |
| Mossiat, C | 3 |
| Beley, A | 3 |
| Marie, C | 3 |
| Millerot-Serrurot, E | 2 |
| Chausset, A | 1 |
| Garnier, P | 2 |
| Faure, P | 1 |
| Bejot, Y | 1 |
| Giroud, M | 1 |
4 other studies available for 2,2'-dipyridyl and Stroke
| Article | Year |
|---|---|
Bipyridine, an iron chelator, does not lessen intracerebral iron-induced damage or improve outcome after intracerebral hemorrhagic stroke in rats.
Topics: 2,2'-Dipyridyl; Animals; Behavior; Body Temperature; Brain Edema; Case-Control Studies; Cell Death; | 2013 |
Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2'-dipyridyl in the rat photothrombotic ischemic stroke model.
Topics: 2,2'-Dipyridyl; Animals; Astrocytes; Brain Ischemia; Cell Survival; Cerebral Cortex; Cerebral Infarc | 2004 |
Effect of early decrease in the lesion size on late brain tissue loss, synaptophysin expression and functionality after a focal brain lesion in rats.
Topics: 2,2'-Dipyridyl; Animals; Body Weight; Brain; Brain Ischemia; Cerebral Cortex; Guanidines; Immunohist | 2007 |
Temporal changes in free iron levels after brain ischemia Relevance to the timing of iron chelation therapy in stroke.
Topics: 2,2'-Dipyridyl; Animals; Brain Ischemia; Chelating Agents; Chelation Therapy; Disease Models, Animal | 2008 |